Goblin House
Claim investigated: The lack of corporate registration results combined with SEC filings suggests MOSAIC may be a financial instrument name (such as a bond, note, or structured product) rather than a standalone corporate entity Entity: MOSAIC Original confidence: inferential Result: STRENGTHENED → SECONDARY
The inference is strongly supported by established evidence patterns. The absence of MOSAIC in corporate registration databases combined with confirmed SEC EDGAR filings spanning 2004-2017 creates a clear evidentiary pattern consistent with financial instrument naming conventions rather than corporate entity status. The concentrated filing activity on August 11, 2006 (multiple simultaneous filings) particularly supports structured product or bond issuance scenarios.
Reasoning: Primary evidence confirms SEC filings exist (2004-2017) while systematic searches found zero corporate registrations. The filing pattern - particularly multiple simultaneous filings on 2006-08-11 - matches typical structured product disclosure requirements. However, without direct access to filing content, this remains well-supported inference rather than definitively proven.
SEC EDGAR: Search MOSAIC filings for Form 424B (prospectus), Form 8-K (current report), or Form 10-K (annual report) to determine filing types
Form types would definitively distinguish between corporate entity filings vs. structured product prospectuses
SEC EDGAR: CUSIP or ISIN identifiers associated with MOSAIC filings
Securities identifiers would confirm financial instrument status and enable tracking across databases
Companies House: MOSAIC as dissolved or struck-off company name variations
Would identify if MOSAIC was ever a registered entity that subsequently dissolved
other: Municipal Securities Rulemaking Board (MSRB) EMMA database for MOSAIC
Would confirm if MOSAIC is a municipal bond or public finance instrument
SIGNIFICANT — This finding resolves a fundamental entity classification question and demonstrates how systematic database analysis can distinguish between corporate entities and financial instruments. It also highlights potential research methodology issues where entity conflation may obscure the actual nature of regulatory filings.